Harry Dolstra (H Dolstra)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 9

Top Topics

Combination Therapy

Top Venues

Cancer immunology, immunotherapy : CII

Cellular and molecular life sciences : CMLS

Cytometry. Part A : the journal of the International Society for Analytical Cytology

This page only lists publications with an associated author ORCID identifier.

Publications

Jesper van Eck van der Sluijs, Diede van Ens, Jolanda Brummelman, Daan Heister, Aastha Sareen, Lisa Truijen, Dorette S van Ingen Schenau, Mirjam H M Heemskerk, Marieke Griffioen, Michel G D Kester, Nicolaas P M Schaap, Joop H Jansen, Anniek B van der Waart, Harry Dolstra, Willemijn Hobo
Human CD34 + -derived complete plasmacytoid and conventional dendritic cell vaccine effectively induces antigen-specific CD8 + T cell and NK cell responses in vitro and in vivo. Cellular and molecular life sciences : CMLS 80 (10) (2023)
Jesper van Eck van der Sluijs, Diede van Ens, Soley Thordardottir, Denise Vodegel, Inge A T Hermens, Anniek B van der Waart, J H Frederik Falkenburg, Michel G D Kester, Iris de Rink, Mirjam H M Heemskerk, Jannie Borst, Nicolaas P M Schaap, Joop H Jansen, Yanling Xiao, Harry Dolstra, Willemijn Hobo
Clinically applicable CD34+-derived blood dendritic cell subsets exhibit key subset-specific features and potently boost anti-tumor T and NK cell responses. Cancer immunology, immunotherapy : CII 70 (11) (2021)
Jolien M R Van der Meer, Paul K J D de Jonge, Anniek B van der Waart, Alexander C Geerlings, Jurgen P Moonen, Jolanda Brummelman, Janne de Klein, Malou C Vermeulen, Ralph J A Maas, Nicolaas P M Schaap, J S Hoogstad-van Evert, Petronella B Ottevanger, Joop H Jansen, Willemijn Hobo, Harry Dolstra
CD34+ progenitor-derived NK cell and gemcitabine combination therapy increases killing of ovarian cancer cells in NOD/SCID/IL2Rgnull mice. Oncoimmunology 10 (1) (2021)
Pieter Fokko van Loo, Basav N Hangalapura, Soley Thordardottir, John D Gibbins, Henrike Veninga, Linda J A Hendriks, Arjen Kramer, Rob C Roovers, Marij Leenders, John de Kruif, Robert P Doornbos, Andres Sirulnik, Mark Throsby, Ton Logtenberg, Harry Dolstra, Alexander B H Bakker
MCLA-117, a CLEC12AxCD3 bispecific antibody targeting a leukaemic stem cell antigen, induces T cell-mediated AML blast lysis. Expert opinion on biological therapy 19 (7) (2020)
Jolien M R Van der Meer, Ralph J A Maas, Karolin Guldevall, K Klarenaar, P K J D de Jonge, J S Hoogstad-van Evert, Anniek B van der Waart, J Cany, J T Safrit, J H Lee, E Wagena, Peter Friedl, Björn Önfelt, Leon F A G Massuger, Nicolaas P M Schaap, Joop H Jansen, Willemijn Hobo, Harry Dolstra
IL-15 superagonist N-803 improves IFNγ production and killing of leukemia and ovarian cancer cells by CD34+ progenitor-derived NK cells. Cancer immunology, immunotherapy : CII 70 (5) (2020)
Charlotte M Mousset, Willemijn Hobo, Aafke de Ligt, Sjoerd Baardman, Nicolaas P M Schaap, Joop H Jansen, Anniek B van der Waart, Harry Dolstra
Cell composition and expansion strategy can reduce the beneficial effect of AKT-inhibition on functionality of CD8+ T cells. Cancer immunology, immunotherapy : CII 69 (11) (2020)
Ralph J A Maas, J S Hoogstad-van Evert, Jolien M R Van der Meer, Vera Mekers, Somayeh Rezaeifard, Alan J Korman, Paul K J D de Jonge, Jeannette Cany, Rob Woestenenk, Nicolaas P M Schaap, Leon F Massuger, Joop H Jansen, Willemijn Hobo, Harry Dolstra
TIGIT blockade enhances functionality of peritoneal NK cells with altered expression of DNAM-1/TIGIT/CD96 checkpoint molecules in ovarian cancer. Oncoimmunology 9 (1) (2020)
Charlotte M Mousset, Willemijn Hobo, Rob Woestenenk, Frank Preijers, Harry Dolstra, Anniek B van der Waart
Comprehensive Phenotyping of T Cells Using Flow Cytometry. Cytometry. Part A : the journal of the International Society for Analytical Cytology 95 (6) (2019)
Charlotte M Mousset, Willemijn Hobo, Yun Ji, Hanny Fredrix, Valeria De Giorgi, Robert D Allison, Michel G D Kester, J H Frederik Falkenburg, Nicolaas P M Schaap, Joop H Jansen, Luca Gattinoni, Harry Dolstra, Anniek B van der Waart
Ex vivo AKT-inhibition facilitates generation of polyfunctional stem cell memory-like CD8+ T cells for adoptive immunotherapy. Oncoimmunology 7 (10) (2018)